Displaying items 10761-10780 of 48055 in total

Incyte's Opzelura Nears EU Approval, Offering Hope for Chronic Eczema

Read full article
Incyte's Opzelura Nears EU Approval, Offering Hope for Chronic Eczema

Vivani’s Board Overhaul Signals High-Stakes Push into GLP-1 Market

Read full article
Vivani’s Board Overhaul Signals High-Stakes Push into GLP-1 Market

The New Architects: How a Startup Exchange is Building the Markets for Tomorrow

Read full article
The New Architects: How a Startup Exchange is Building the Markets for Tomorrow

InMode Buyout Battle: Shareholder Alleges CEO Exploits Low Valuation

Read full article
InMode Buyout Battle: Shareholder Alleges CEO Exploits Low Valuation

From Court to Capital: Djokovic's New Game in Global Finance

Read full article
From Court to Capital: Djokovic's New Game in Global Finance

Aethlon’s Blood Filter Reveals a New Target in the Fight Against Long COVID

Read full article
BriefGlance

VulcanForms Taps Aerospace Veteran to Scale an American Factory of the Future

Read full article
VulcanForms Taps Aerospace Veteran to Scale an American Factory of the Future

Nevada King Levels Up: OTCQX Listing Unlocks New Horizons for U.S. Investors

Read full article
Nevada King Levels Up: OTCQX Listing Unlocks New Horizons for U.S. Investors

Daiichi & AstraZeneca's Datroway Nears EU Approval in Major Cancer Win

Read full article
Daiichi & AstraZeneca's Datroway Nears EU Approval in Major Cancer Win

The Sidewinder's Echo: A $1.1B Deal and the New Deterrence Economy

Read full article
BriefGlance

Nature's New IPO: A Bold Bid to Financialize the World's Ecosystems

Read full article
Nature's New IPO: A Bold Bid to Financialize the World's Ecosystems
Sponsored

Kyivstar Paves Way for Ukrainians to Invest in a National Champion on Nasdaq

Read full article
Kyivstar Paves Way for Ukrainians to Invest in a National Champion on Nasdaq

Jade Biosciences Taps Biotech Heavyweight to Guide Its Autoimmune Ambitions

Read full article
Jade Biosciences Taps Biotech Heavyweight to Guide Its Autoimmune Ambitions

Cineverse's Pivot: Inside the High-Stakes Bet on AI Over Film Hits

Read full article
Cineverse's Pivot: Inside the High-Stakes Bet on AI Over Film Hits

The Millisecond Advantage: Redefining Investor Trust in China's Digital Age

Read full article
The Millisecond Advantage: Redefining Investor Trust in China's Digital Age

Tradr Doubles Down on Tech Volatility with New Leveraged ETFs

Read full article
Tradr Doubles Down on Tech Volatility with New Leveraged ETFs

Roundhill's $30B Milestone Signals a New Era for Thematic Investing

Read full article
Roundhill's $30B Milestone Signals a New Era for Thematic Investing

Cyber Insurance's Dangerous Game: Prices Fall as Losses Mount

Read full article
Cyber Insurance's Dangerous Game: Prices Fall as Losses Mount

The Network’s New Nerve Ending: A Tiny Chip Wiring the Physical World for AI

Read full article
The Network’s New Nerve Ending: A Tiny Chip Wiring the Physical World for AI

The Unseen Guardian: How AI is Redefining Hospital Security in Ontario

Read full article
The Unseen Guardian: How AI is Redefining Hospital Security in Ontario